See more : MedAdvisor Limited (MDR.AX) Income Statement Analysis – Financial Results
Complete financial analysis of TOP Financial Group Limited (TOP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TOP Financial Group Limited, a leading company in the Financial – Capital Markets industry within the Financial Services sector.
- Medical Cannabis Payment Solutions, Inc. (REFG) Income Statement Analysis – Financial Results
- O’will Corporation (3143.T) Income Statement Analysis – Financial Results
- Steamships Trading Company Limited (SST.AX) Income Statement Analysis – Financial Results
- Sichuan Fulin Transportation Group Co., Ltd. (002357.SZ) Income Statement Analysis – Financial Results
- Kolon Global Corporation (003075.KS) Income Statement Analysis – Financial Results
TOP Financial Group Limited (TOP)
About TOP Financial Group Limited
TOP Financial Group Limited, through its subsidiaries, operates as an online brokerage company in Hong Kong. It is involved in the trading of local and overseas equities, futures, and options products; and the provision of brokerage and value-added services, including trade order placement and execution, account management, and customer support services. The company provides a range of futures products, such as index futures, forex futures, agricultural product futures, energy futures, and precious metal futures. It also offers stock brokerage, options brokerage, consulting services, currency exchange services, structured note subscriber services, and margin financing services. The company was formerly known as Zhong Yang Financial Group Limited and changed its name to TOP Financial Group Limited in July 2022. The company was founded in 2015 and is based in Hong Kong, Hong Kong. TOP Financial Group Limited is a subsidiary of Zhong Yang Holdings (BVI) Limited.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 8.04M | 9.70M | 7.82M | 16.91M | 16.50M | 10.78M |
Cost of Revenue | 3.69M | 3.83M | 3.29M | 10.95M | 13.13M | 0.00 |
Gross Profit | 4.35M | 5.87M | 4.53M | 5.95M | 3.37M | 10.78M |
Gross Profit Ratio | 54.14% | 60.51% | 57.92% | 35.21% | 20.42% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 2.22M | 2.25M | 949.76K | 836.72K | 771.43K | 166.37K |
Selling & Marketing | 1.67M | 188.96K | 53.34K | 16.88K | 52.17K | 828.92K |
SG&A | 3.89M | 2.44M | 949.76K | 836.72K | 771.43K | 995.29K |
Other Expenses | 0.00 | -3.33M | -1.45M | -1.51M | -1.41M | 0.00 |
Operating Expenses | 3.89M | 2.44M | 949.76K | 836.72K | 771.43K | 9.26M |
Cost & Expenses | 3.89M | 6.27M | 4.24M | 11.79M | 13.90M | 9.26M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 144.50K | 120.95K | 64.58K | 13.29K | 17.87K | -1.53M |
EBITDA | 1.13M | 3.55M | 3.64M | 5.13M | 2.62M | 18.05M |
EBITDA Ratio | 14.09% | 36.62% | 46.60% | 30.34% | 15.85% | 0.00% |
Operating Income | 4.15M | 3.43M | 3.58M | 5.12M | 2.60M | 1.53M |
Operating Income Ratio | 51.66% | 35.37% | 45.78% | 30.26% | 15.74% | 14.15% |
Total Other Income/Expenses | -3.16M | 0.00 | 0.00 | 0.00 | 0.00 | -8.26M |
Income Before Tax | 987.85K | 3.43M | 3.58M | 5.12M | 2.60M | 1.53M |
Income Before Tax Ratio | 12.29% | 35.37% | 45.78% | 30.26% | 15.74% | 14.15% |
Income Tax Expense | -63.69K | 31.52K | 88.65K | 70.77K | 58.44K | 241.25K |
Net Income | 1.05M | 3.40M | 3.49M | 5.04M | 2.54M | 1.28M |
Net Income Ratio | 13.08% | 35.04% | 44.64% | 29.84% | 15.39% | 11.91% |
EPS | 0.03 | 0.10 | 0.10 | 0.14 | 0.07 | 0.03 |
EPS Diluted | 0.03 | 0.10 | 0.10 | 0.14 | 0.07 | 0.03 |
Weighted Avg Shares Out | 32.28M | 35.00M | 35.75M | 35.75M | 35.75M | 50.00M |
Weighted Avg Shares Out (Dil) | 32.28M | 35.00M | 35.75M | 35.75M | 35.75M | 50.00M |
RLF, A TOP-RANKED LAW FIRM, Encourages Orthofix Medical Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – OFIX
RLF, A TOP-TANKED LAW FIRM, Encourages Paragon 28, Inc. Investors to Secure Counsel Before Important November 29 Deadline in Securities Class Action First Filed by the Firm – FNA
OM DEADLINE: RLF, A TOP-RANKED LAW FIRM, Encourages Outset Medical, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – OM
RLF, A TOP RANKED LAW FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN
ROSEN, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGE
ROSEN, A TOP-RANKED LAW FIRM, Encourages WEBTOON Entertainment Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBTN
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Terran Orbital Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – LLAP
ROSEN, A TOP-RANKED LAW FIRM, Encourages Spire Global, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – SPIR
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages WM Technology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MAPS
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM
Source: https://incomestatements.info
Category: Stock Reports